News
When it comes to the use of PD-1 inhibitors in stomach cancer, the FDA has put its money where its mouth is. | After ...
2h
Zacks.com on MSNAcquisitions, Licensing Deals Take Centerstage in Pharma/Biotech SpaceSNY, BMY, REGN and others ramp up 2025 dealmaking as pharma/biotech giants chase innovation across key growth areas.
A groundbreaking lung cancer screening project co-led by the University of Kentucky Markey Cancer Center and the University ...
'We are in a good spot': Gilead's new chief medical officer is committed to pipeline diversification
Dietmar Berger, M.D., Ph.D., joined Gilead Sciences as chief medical of | Dietmar Berger became Gilead Sciences’ new chief ...
ASCO 2025 delivered pivotal updates. In this article, we discuss 8 of the more interesting abstracts from an investment ...
Giving patients more direct control over their healthcare data is a frequent talking point among healthcare leaders. | The ...
Global trade uncertainty and evolving tariff policies are shifting how bioscience companies view their supply chains. | ...
Martias Joshua has reaffirmed government’s commitment to support initiatives to improve lung cancer awareness and access to ...
And with an eye to today’s Apple’s Worldwide Developers Conference, investors are hoping that technology stocks will help ...
The Bambino is taking a curtain call. Remus Bourbon, the award-winning whiskey inspired by the roaring spirit of the prohibition, is proud to announce the next chapter of its official partnership with ...
During a session at the Heart in Diabetes CME Conference, speakers highlighted four papers recently published in Circulation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results